Back

Mechanistic insights of SGLT2 inhibitors effectiveness

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: The therapeutic conundrum in HFpEF Chronic Heart Failure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Gheorghe Andrei Dan

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)

3 More presentations in this session

Presentation thumbnail
Mineralocorticoid receptor antagonist drugs in HFpEF
Professor M. Crespo-Leiro (A Coruna, ES)
Slides Video
Presentation thumbnail
Pharmacotherapy targeting inflammation in HFpEF
Professor K. Hasegawa (Kyoto, JP)
Slides Video
Presentation thumbnail
GLP-1 receptor agonist (GLP-1 RA) and gastric inhibitory polypeptides (GIPs) in HFpEF
Professor T. McDonagh (London, GB)
Slides Video

Access the full session

Session thumbnail
The therapeutic conundrum in HFpEF
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Effects of empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: results from in-vivo experiments and the CINNAMON-study
thumbnail
Congress Presentation
Empagliflozin preserves hemodynamics and left ventricular function in nephrectomized rats after ischemia-reperfusion injury: a potential direct cardioprotective effect of SGLT2 inhibitor
thumbnail
Congress Presentation
Unravel novel therapeutic targets in heart failure and associated pulmonary hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources